BioCentury
ARTICLE | Clinical News

Activa PC Neurostimulator: Clinical trial amended

June 24, 2013 7:00 AM UTC

Functional Neuromodulation said FDA approved to increase enrollment to up to 50 patients from 20 patients ages 55-80 years with mild AD in the double-blind, U.S. and Canadian ADvance trial evaluating ...